This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Aprinoia Therapeutics Limited. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: Innovations of Chin-Yin Tai in Neurodegenerative Disease Research
Introduction
Chin-Yin Tai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of 2 patents, Tai's work focuses on developing therapeutic solutions for conditions associated with pathological Tau aggregation.
Latest Patents
Chin-Yin Tai's latest patents include groundbreaking work on antibodies that bind to pathological Tau species. The first patent details antibodies that selectively target pathological Tau, providing compositions and methods for treating tauopathies and neurodegenerative diseases. This innovative approach aims to address the challenges posed by the pathological aggregation of Tau, which is a hallmark of various neurodegenerative disorders. The second patent reiterates the same focus on antibodies that bind to pathological Tau species, emphasizing their potential uses in therapeutic applications.
Career Highlights
Chin-Yin Tai is associated with Aprinoia Therapeutics Limited, where he continues to advance his research in the field of neurodegenerative diseases. His work is characterized by a commitment to developing effective treatments that can improve the quality of life for individuals affected by these conditions. Tai's innovative spirit and dedication to research have positioned him as a key figure in the scientific community.
Collaborations
Chin-Yin Tai collaborates with Ming-Kuei Jang, further enhancing the research efforts at Aprinoia Therapeutics Limited. Their combined expertise contributes to the development of novel therapeutic strategies aimed at combating neurodegenerative diseases.
Conclusion
Chin-Yin Tai's contributions to the field of neurodegenerative disease research through his patented innovations highlight the importance of targeted therapies in addressing complex medical challenges. His work continues to inspire advancements in the treatment of tauopathies and related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile